| year | 2026Latest | 2025 | 2024 |
|---|---|---|---|
Revenue | 0 € | 0 € -100.0% | 10,6m € -39.4% |
Profit | - | - +100.0% | -230k € -109.1% |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - | - -100.0% | 2,5m € -10.6% |
Employees | 4 +0.0% | 4 | - |
Overall rating | B68/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 60/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | - | |||
| - | Member | - |
N/A
N/A
N/A
DAAAK Pharma Int. AS is located at Harju maakond, Tallinn, Kesklinna linnaosa, Hobujaama tn 4, 10151.
In 2026, DAAAK Pharma Int. AS had an average of 4 employees. View tax history →
The beneficial owners of DAAAK Pharma Int. AS are Jelena Lerner. View ownership details →
No, DAAAK Pharma Int. AS does not have an active VAT number and is not registered as a VAT payer.
In 2026, the average gross salary at DAAAK Pharma Int. AS was approximately 1177,79 € per month (net ~ 903,98 €). This is an approximate calculation. View salary details →
DAAAK Pharma Int. AS was founded on June 11, 2015. The company has been operating for 11 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 11 years | - | 0% | |
Registered capital | 25 000,00 € | - | 0% |
Annual financial report for 2026.
Annual financial report for 2025.
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Registered in the Estonian business register.
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Jelena Lerner | EE | - |